Skip to main content
logo
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.000
+0.010 (0.50%)
At close: May 15, 2026, 4:00 PM EDT
1.992
-0.008 (-0.41%)
After-hours: May 15, 2026, 7:19 PM EDT

TherapeuticsMD Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2319102653155
Market Cap Growth
43.78%90.22%-61.78%-51.13%-65.69%-57.33%
Enterprise Value
19.5516.510.428.1522.497.92
Last Close Price
2.001.630.862.255.5918.00
PE Ratio
269.18-32.60-4.53-3.040.47-1.81
PS Ratio
6.906.245.6319.930.7660.15
PB Ratio
0.860.700.360.891.51-1.65
P/TBV Ratio
0.860.700.360.801.49-1.53
P/FCF Ratio
8.667.698.48-1.125.67-2.81
P/OCF Ratio
8.667.698.48-1.125.67-2.81
EV/Sales Ratio
5.835.465.9121.620.3238.06
EV/EBITDA Ratio
--4.12-1.86-3.709.39-1.24
EV/EBIT Ratio
--3.76-1.70-3.3018.80-1.23
EV/FCF Ratio
7.316.738.89-1.222.39-1.77
Debt / Equity Ratio
0.180.190.200.220.21-0.09
Debt / EBITDA Ratio
-0.96-1.28-0.99-0.863.09-2.49
Debt / FCF Ratio
1.792.094.74-0.280.79-3.56
Net Debt / Equity Ratio
-0.13-0.090.020.08-0.87-1.40
Net Debt / EBITDA Ratio
0.720.59-0.09-0.29-12.88-1.67
Net Debt / FCF Ratio
-1.33-0.960.41-0.10-3.28-2.38
Asset Turnover
0.090.080.040.020.540.01
Inventory Turnover
-----0.35
Quick Ratio
2.372.301.671.080.810.26
Current Ratio
3.113.022.371.721.180.47
Return on Equity (ROE)
0.32%-2.41%-8.16%-23.90%-3.67%72.88%
Return on Assets (ROA)
-10.46%-11.48%-14.69%-12.67%0.92%-45.33%
Return on Invested Capital (ROIC)
-14.32%-14.77%-17.95%-25.22%2.00%-122.67%
Return on Capital Employed (ROCE)
-16.48%-13.20%-17.44%-21.29%-5.98%-408.58%
Earnings Yield
0.77%-3.07%-22.09%-32.89%213.95%-55.33%
FCF Yield
11.55%13.01%11.80%-88.95%17.63%-35.65%
Buyback Yield / Dilution
-0.47%-0.32%-10.45%-11.48%-17.66%-44.39%
Total Shareholder Return
-0.47%-0.32%-10.45%-11.48%-17.66%-44.39%
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q